Laboratory Approach to Patient with Bleeding (Hemostasis) Disorder Dr.Nadjwa ZD, SpPK-K.

Slides:



Advertisements
Similar presentations
Bleeding time is a medical test done on someone to assess their platelet function, count and integrity of the blood vessels.
Advertisements

Basic coagulation techniques and Quality control issues
Coagulation Bruno Sopko.
Pre-analytical factors that can affect coag test results
General Approach of Haemostasis
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Basic Principles of Hemostasis
Gatmaitan, Raymond Vincent Golpeo, Kirsten C.
General Approach in Investigation of Haemostasis
Coagulation Time Tube Method Mr. Mohammed A. Jaber.
Bleeding time,clotting time, PT, and PTT
Coagulation Tests Mr. Mohammed A. Jaber.
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
Dr MOHAMMED H SAIEMALDAHR FACULTY of Applied Medical Sciences
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Coagulation Time of whole blood
Hemostasis and Blood Coagulation
MLAB Coagulation Keri Brophy-Martinez
General Approach of Haemostasis
Erythrocyte Count Normal ranges:
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
MIXING STUDIES General Approach of Haemostasis
Hemostasis. Hemostasis Definition Prevention of blood loss (stoppage of blood flow)
  The prothrombin time is therefore the time required for the plasma to clot after an excess of thromboplastin and an optimal concentration of calcium.
SCREENING COAGULATION STUDIES When & when NOT to do them.
Blood Groups Clotting Time and Bleeding Time. Aims of the Practical To determine: 1.Blood groups. 2.Clotting time. 3.Bleeding time.
In this exercise, two tests will be performed to screen for defective clotting factors. The formation of thrombin in the plasma samples will be inhibited.
Investigation of Haemostasis MS. c. program Lab-9.
To understand blood coagulation tests it is helpful to have a basic understanding of the role of the different blood clotting factors and the coagulation.
Activated Partial Thromboplastin Time (aPTT)
HEMOSTASIS When blood vessels are cut or damaged, the loss of blood from the system must be stopped before shock and possible death occur. This is accomplished.
Mrs. Ibtisam H. Alaswad Mr. Mohammed A. Jaber COAGULATION TESTS.
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
Hemostasis and Coagulation Hemostasis Hemostasis is the maintenance of circulating blood in the liquid state and retention of blood in the vascular system.
Bleeding time BLEEDING TIME: the time that elapses between the puncture of the skin and the stoppage of blood oozing using a lancet. Why Do I Need a Bleeding.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Bleeding time It is the time that elapses between the puncture of the skin and the stoppage of blood oozing.
Chapter 17 Coagulation Testing
Chapter 23. Bleeding disorders associated with coagulopathy
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Lab Work 3 SDV1- Physiology II Bleeding time, clotting time and BP
MLAB Coagulation Keri Brophy-Martinez
Bleeding Disorders Last update
These factors prevent blood clotting - in normal state.
BLOOD GROUPS.
General Approach of Haemostasis
General Principles of Hemostasis Kristine Krafts, M.D.
General Approach in Investigation of Hemostasis
Tests for hemostasis (Practical)
Mrs. Ibtisam H. Alaswad Mr. Mohammed A. Jaber
University of North Carolina-Chapel Hill Division of Hematology
Mixing Studies-aPTT or PT 1:1 Mix
Hemostasis.
Hemodynamic disorders (1 of 3)
Coagulation Cascade of the Newborn
Tests for Hemostasis (Bleeding time and Clotting time)
Activated Partial Thromboplastin Time (aPTT)
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Blood type, bleeding time, clotting time and osmotic fragility
General Principles of Hemostasis Kristine Krafts, M.D.
Enas Sabah MSc. Human Physiology
Principles of Coagulation Screening II
Hemostasis and Coagulation
Presentation transcript:

Laboratory Approach to Patient with Bleeding (Hemostasis) Disorder Dr.Nadjwa ZD, SpPK-K

Hemostasis is achieved by highly integrated and regulated interaction of Blood vessels Platelets Coagulation proteins Fibrinolysis Natural anticoagulant

Hemostasis Disorders Bleeding and/or thrombosis Bleeding and/or thrombosis Bleding Bleding – Vascular – Platelet*(ITP) – Coagulation factors*(vWD,Hemophilia) Thrombosis* Thrombosis* – Fibrinolysis – Natural anticoagulant Both  DIC Both  DIC

4 Approach to Hemostasis Disorders Clinical: Clinical: – History taking – Physical Examination Laboratory Laboratory

5 History Taking Family history Family history Drugs used Drugs used Previous diseases Previous diseases Symptoms Symptoms

6 Physical Examination Petechaie Petechaie Ecchimosis Ecchimosis Hematom Hematom Epistaxis Epistaxis Gingival bleeding Gingival bleeding Metro-menorrhagia Metro-menorrhagia

7 Hemostasis Test Screening Screening Confirmatory Confirmatory

Hemostasis Tests Screening assays in hemostasis: 1.Patients without any signs/symptoms  preoperative. 2.Patient with bleeding 3.Monitoring of anticoagulant therapy 4.Disseminated Intravascular Coagulation 5.Thrombophilia 6.Inhibitor (Lupus Anticoagulant, Anti Phospholipid Antibody)

9 Hemostasis Screening Test 1.Tourniquet Test 2.Bleeding Time 3.Clotting Time 4.Clot Retraction 5.Platelet Count* 6.PT* 7.APTT* 8.TT* 9.Fibrinogen* 10.Euglobulin Clot Lysis Test 11.D-Dimer*Thrombelastography

Tourniquete Test = Capillary Resistance Test. = Rumpel Leede Test = Hess’s Test Principle : This test measures the ability of the capillaries to resist pressure. In healthy individu, the capillaries in the arm will resist a pressure of 100 mmHg. If the capillaries can not resist, they will break or rupture, tiny spot will then appear. These spots are hemorrhages or petechiae.

Purpose To evaluate capillary resistance Equipments Sphygmomanometer Stethoscope Stopwatch Marker

Procedure : Draw with marker a circle (5 cm in diameter) in the volar surface of the forearm, about 5 cm below the elbow. Apply a blood pressure cuff on the upper arm, determine a systolic and diastolic pressures, and then deflate to a pressure midway between the two. Leave the inflated cuff in place for 5 minutes Remove the cuff, wait for 5 minute

Interpretation Inspect the circle for petechiae Normal : < 10 petechiae > 10 petechiae  abnormal, due to : – Increased capillary resistance – Decreased platelet number

TOURNIQUET TEST 5 cm SYSTOLICDIASTOLIC 5 min 100 mmHg Leave for 5 min petechiae

Bleeding Time Duke Method Ivy Method

BLEEDING TIME (Duke’s Method) Principle : The skin is incised, blood flowing out is aspirated with a filter paper, and then the time until hemostasis is measured. Purpose : To evaluate platelet and vascular ability in performing platelet plug.

Equipments Blood lancet. Cotton ball soaked in alcohol 70%. Circular filter paper. Stop watch

Procedure The lobe of the ear is cleaned with 70% of alcohol and let dried Use a blood lancet to puncture earlobe to a depth of 3 mm. Start timing (stop watch) Every half minute, gently apply the edge of a small disc of filter paper to the drops of blood from the earlobe – do not touch the skin. Use a fresh edge of filter paper disc for each half-minute blotting.

BLEEDING TIME FILTER PAPER 5 mm 1. DUKE METHOD (ear lobe) VASCULAR VASCULAR PLATELET PLATELET Every 30 sec

Interpretation Time in minutes equals number of blots divided by 2 Normal : 1-3 minutes

When the blood spot becomes 1 mm or smaller, stop the stop watch. If the bleeding doesn’t stop in 10 min., discontinue testing. Indicate the result as 10 min or longer. Cover the wound with a sterile gauze for a while, hemostasis should be confirmed, after which the patient may leave.

Note : The size of the blood spot about 1 cm in diameter is desirable, but becomes larger in some cases. However bleeding usually stops for several minutes regardless of the size. Don’t wipe off the blood. Gently touch. Note so as not to touch the wound.

Bleeding time (Ivy Method) Ivy Method is more reliable than Duke Method. Equipment : – Sphygmomanometer – Sterile disposable lancet (capable of making an incision of 1 mm wide and 3 mm deep) – Circular filter paper – Alcohol 70% – Cotton wool or surgical gauze

Procedure : Place the sphygmomanometer cuff on the patient’s arm, above the elbow. Inflate the cuff to 40 mm of mercury and hold this exact pressure for the entire period. Choose an area approximately 3 fingerwidths below the bend in the elbow on the volar surface. Clean the area with the alcohol sponge.

Hold the skin tightly by grasping the under- side of the arm firmly and make 2 separate punctures 5 to 10 cm apart, in quick succession, using the disposable lancet. Start the stopwatch. Note : it is essential for you to be purposeful and precise as tentative jabs may not bleed satisfactorily. Avoid any subcutaneous veins. The disposable lancet available for this purpose can be inserted freely to its maximum depth without fear of penetrating too deeply.

Blot the blood from each incision site on a separate piece of circular filter paper every 30 sec. The filter paper should not touch the incision point at any time When bleeding ceases, stop the watch and release the blood pressure cuff. Record the bleeding times of the 2 punctures

Interpretation Normal : up to 11 min. If bleeding continuous for > 15 min, apply pressure to the wound site, and report the result as greater than 15 min.

- 3 Cm  Drops of blood that come from the incision point is blotted with the circular filter paper every 30seconds  NORMAL:1-7 Minute  The depth of the puncture must be deep enough, so that it leaves a blot with a diameter of 5 mm BP : 40 mmHg BLOOD LANCET 2. IVY METHOD :

CLOT RETRACTION Principle When whole blood is allowed to clot spontaneously, the initial coagulum is composed of all elements of the blood. With time the coagulum reduces in mass, and fluid serum is expressed from the clot, and its volume stated in %. This is due to an action of platelets on the fibrin network.

Sample : 5 ml blood obtained from vein Instruments : 1.A set of devices for blood sampling from vein. 2.Centrifuge glass test tube. 3.Stick (lidi) 4.Centrifuge

Procedure 1.Obtain 5 mL of venous blood. 2.Take off the needle and transfer blood into the test tube. Put the tube on the rack. 3.Leave at room temperature for about 1,5-2 hours. 4.After 2 hours, separate the blood clot from the test tube’s wall carefully, placed the blood clot into another test tube. 5.Centrifuge the serum for about 5 min/1000 rpm. 6.Measure how much (mL) serum was performed and calculate the percentage.

Hemocytometer Platelet Count (manual)

MANUAL REAGENT TROMBOCYTE

Clotting Time Bedside Clotting Time Clotting Time Lee & White Method

BEDSIDE CLOTTING TIME Principle : Record the time interval from the blood contact with glass surface, until fibrin network is performed at the room temperature. Sample : Capillary blood

Equipments 1.Clean, oil free and smooth object glass. 2.Stopwatch. 3.Needle. 4.Sterile blood lancet. 5.Cotton ball soaked in alcohol 70 %.

PROCEDURE 1.Clean the finger tip with70% of alcohol, let it dry. 2.Puncture with blood lancet, 3 mm in depth. 3.Wipe the first blood drop with dry cotton. 4.Drop the next blood drop onto the object glass (4-5 mm in diameter) and start stopwatch immediately as the blood touch glass surface. 5.Put the second drop beside the first one with same size diameter. 6.Watch the fibrin thread formed in the second drop of blood by tilt it with a needle every 30 sec. 7.When the fibrin was performed, do the same step to the first blood drop and stop the stopwatch if the fibrin was seen in the first drop. 8.Record the time.

Clotting Time : Lee & White blood 3 ml 37 o C 1 cc 1 cc 1cc N : 5 – 11 min

Coagulation Tests PT APTT TT Manual Automatic (Coagulometer)

Coagulometer

Prothrombin Time (PT) Screening test for the extrinsic and common pathways of coagulation (factors II, VII, V, X). Limited sensitivity to fibrinogen. Normal range : sec

INR (International Normalized Ratio) To overcome some of the difficulties with the variability of thromboplastin  normalizing the responses of thromboplastin reagents against an international standard. INR = { } PT pat PT n ISI

ISI (International Sensitivity Index) Needs to be developed for each thromboplastin reagent and instrument combination used in performing PT and calculation of INR. Ideal reagent  ISI < 1.7

Activated Partial Thromboplastin Time (aPTT) Screening test for the intrinsic and common pathways of coagulation (factors XII, XI, IX, VIII, X, V and II). Limited sensitivity to fibrinogen. Maybe normal in some cases of vWD Normal range : < 35 sec

Substitution Test (Mixing Study) APTT To evaluate factors deficiency Additional reagents : – Adsorbed Plasma (consist of factors : I, V, VIII, XI, XII). – Aged Serum (consist of factors : VII, IX, X, XI, XII).

SUBSTITUTION TEST FACTOR DEFICIENT XII PTT A P T N TT N NP C AP C AS C XIANNCCC IXANNCUCC VIIIANNCCUC XAANCC VAANCC VIINA---- IIAANCUC IAAACC HEPARIN OR INHIBITOR RESEMBLE HEPARIN AAAUC-- PTT - PARTIAL THROMBOPLASTIN TIME NP - NORMAL PLASMA PT - PROTHROMBIN TIME AP - ADSORBED PLASMA TT - THROMBIN TIME AS - AGED SERUM A = ABNORMAL N = NORMAL C = CONTROL UC= UNCONTROL

Thrombin Time (TT) Identified stage 3 defects in the coagulation mechanism Clinical significant  Prolonged TT : – Decreased fibrinogen concentration – Presence of dysfunctional fibrinogen – Presence of heparin – Presence of FDP

D-dimer

Thromboelastography Screening & control therapy Easy to perform, no reagent needed, fast Record clot formation and converse to graph TEG ruler Conversion table

PISTON CUVET

1. TEG NORMAL PATTERN r = reaction time (start to amplitudo 1 mm) k = coagulation time (end of r to amplitudo 20 mm) m.a = maximum amplitudo (mm) m. e= maximum elasticity 100 x a m. e = a r k 20 mm m. a

r k m. a 2. THROMBOCYTOPENIA r = normal k = normal/prolonged m.a. = shortened 3. HYPERFIBRINOLYSIS m.a r k r = normal k = normal m.a. = previously normal, but suddenly become shortened

r k 4. HEMOPHILIA r = prolonged k = prolonged m.a. = normal/shortened m. a 5. HYPERCOAGULATION r k m.a r = shortened k = shortened m.a = prolonged

Normal Hemophilia Thrombocytopenia Hyperfibrinolysis Hypercoagulation TEG pattern

Confirmatory Tests Vascular Platelet : – Platelet adhesion – Platelet aggregation Coagulation : – Substitution test – Factor Assay Fibrinolysis

TestResultDifferential diagnosis PTN - Normal- Von Willebrand disease (mild) APTTN - Mild trombocyte disfunction - Fibrinolysis abnormality TTN Fibr.N - Vaskuler abnormality Tromb.N 1

TestResultDifferential diagnosis PTL - F VII deficiency APTTN - Initial phase of oral anticoagulant therapy TTN - Lupus anticoagulant Fibr.N - Faktor II, V or X deficiency (mild) Tromb.N 2

TestResultDifferential diagnosis PTN - Faktor VIII, IX, XI, XII, Prekalikrein, HMWK deficiency APTTL - Circulating anticoagulant - Von Willebrand disease TTN - Faktor II, V atau X deficiency (mild) Fibr.N Tromb.3N 3

TestResultDifferential diagnosis PTL - Vit.K deficiency- Combined F V and F VIII deficiency APTTL - Oral antikoagulant TTN - F V, II, X deficiency Fibr.N - Liver disfunction  coagulation factor deficiency Tromb.N 4

TestResultDifferential diagnosis PTL - Heparin APTTL - Liver disease TTL - Fibrinogen deficiency Fibr.N/A - Polimerization fibrin inhibition Tromb.N - Hyperfibrinolisis 5

TestResultDifferential diagnosis PTN - Trombocytopenia APTTN TTN Fibr.N Tromb.Low 6

TestResult Differential diagnosis PTL - Massive transfusion APTTL - Liver disease TTN Fibr.N/A Tromb.Low 7

TestResultDifferential diagnosis PTL - DIC APTTL - Acute liver disease TTL Fibr.Low Tromb.Low 8

Thank You